Consequences of OSA Source: Annual Congress 2012 - PG5 Obstructive sleep apnoea syndrome Year: 2012
Evaluation of cerebral metabolism after CPAP treatment in OSAS patients Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009
Chronic hypercapnia in patients with OSAS with and without COPD Source: Eur Respir J 2005; 26: Suppl. 49, 569s Year: 2005
Can the nocturnal apnoea increase the oxidative stress in OSA patients? Source: Eur Respir J 2002; 20: Suppl. 38, 215s Year: 2002
Effects of CPAP treatment in UARS patients comparing to OSAS patients Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007
Chronic daytime hypercapnia in patients with OSAS – what is to blame? Source: Eur Respir J 2006; 28: Suppl. 50, 418s Year: 2006
Prevalence of day-time hypercapnia or hypoxia in patients with OSAS and normal lung function Source: Eur Respir J 2002; 20: Suppl. 38, 493s Year: 2002
Auto-CPAP for treatment of OSAS in severe obese patients Source: Eur Respir J 2005; 26: Suppl. 49, 723s Year: 2005
Treating OSAS in children Source: International Congress 2017 – ME1 Treating obstructive sleep apnoea syndrome in children Year: 2017
The impact of OSA on nocturnal hypoxia in obese patients with chronic asthma Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA Year: 2012
Chronic hypercapnia in morbidly obese patients with obstructive sleep apnea syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 569s Year: 2005
Daytime hypercapnia in patients with OSAHS Source: Eur Respir J 2003; 22: Suppl. 45, 275s Year: 2003
Metabolic syndrome, systemic inflammation and oxidative stress in patients with severe obstructive sleep apnea: effects of CPAP Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008
Oxidative stress in patients with moderate to severe obstructive sleep apnea Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea Year: 2010
Cardiovascular and metabolic effects of CPAP in obese obstructive sleep apnoea patients Source: Eur Respir J 2008; 31: 223-225 Year: 2008
Metabolic abnormalities in OSA patients Source: Eur Respir J 2007; 30: Suppl. 51, 491s Year: 2007
Determinants of hypercapnia in obese obstructive sleep apnea (OSA) patients Source: Eur Respir J 2004; 24: Suppl. 48, 447s Year: 2004
The effect of CPAPn treatment in oxidative stress in patients with SAHS Source: Eur Respir J 2006; 28: Suppl. 50, 574s Year: 2006
Severity of sleep apnea and daytime hypoxemia do not significantly contribute to endothelial dysfunction in morbidly obese subjects Source: Annual Congress 2010 - Sleep apnoea: insights from basic and clinical research Year: 2010
CPAP vs APAP effects on metabolic and cardiac function in patients with OSAS Source: Eur Respir J 2005; 26: Suppl. 49, 722s Year: 2005